-
PDF
- Split View
-
Views
-
Cite
Cite
Stephan J Guyenet, Susan E Carlson, Increase in Adipose Tissue Linoleic Acid of US Adults in the Last Half Century, Advances in Nutrition, Volume 6, Issue 6, November 2015, Pages 660–664, https://doi.org/10.3945/an.115.009944
Close -
Share
ABSTRACT
Linoleic acid (LA) is a bioactive fatty acid with diverse effects on human physiology and pathophysiology. LA is a major dietary fatty acid, and also one of the most abundant fatty acids in adipose tissue, where its concentration reflects dietary intake. Over the last half century in the United States, dietary LA intake has greatly increased as dietary fat sources have shifted toward polyunsaturated seed oils such as soybean oil. We have conducted a systematic literature review of studies reporting the concentration of LA in subcutaneous adipose tissue of US cohorts. Our results indicate that adipose tissue LA has increased by 136% over the last half century and that this increase is highly correlated with an increase in dietary LA intake over the same period of time.
Introduction
Linoleic acid (LA) (18:2n–6) is an 18-carbon n–6 PUFA with diverse effects on human physiology. LA is linked to skin barrier (1), immune (2), cardiovascular (3, 4), and neurobiological (5) functions, and, as a precursor of arachidonic acid and its metabolites, to reproductive (6), thermoregulatory, and digestive functions (7). In addition, LA is a natural ligand for PPARs (8). PPARs are intimately involved in the regulation of metabolic functions, including lipid and glucose metabolism, and they have been implicated in obesity and cardiometabolic disease risk (9). PPARα agonism may contribute to the ability of dietary LA to reduce circulating concentrations of total and LDL cholesterol (10). Finally, LA can influence biological processes via its nonenzymatic oxidation products. Oxidation of lipids in LDL is a risk marker for coronary heart disease (11). Because of its abundance in LDL and susceptibility to oxidation, LA is the most commonly oxidized species in LDL (12). The LA content of LDL reflects dietary intake (13).
Many seed oils are rich in LA, and consumption in the United States has increased substantially over the last half century (14). Much of this increase has come from soybean oil, which contains between 50% and 60% of total FAs as LA (14). Adipose tissue concentration of LA is particularly responsive to dietary LA, as demonstrated by diet modification trials (10). As such, it is used as a biomarker of dietary intake (15). We hypothesized that increases in dietary LA in the US food system have led to increased adipose tissue concentrations of LA. To test this hypothesis, we conducted a systematic literature review of studies that have reported the LA concentration of subcutaneous adipose tissue. Our findings suggest that adipose tissue LA has more than doubled in the United States over the last half century and correlates strongly with LA in the US food supply, potentially influencing numerous aspects of human physiology and pathophysiology.
Methods
To identify studies, a systematic search was conducted in May 2015 with the use of the PubMed and Google Scholar databases. Search terms included “adipose tissue fatty acids,” “adipose tissue” and “fatty acids,” and “adipose linoleic acid” and “adipose 18:2.” Manuscripts were manually searched for additional references. All studies that reported adipose tissue LA concentration in US subjects before May 2015 were considered. Studies were excluded if subjects were infants, followed an atypical diet, or were diagnosed with a disease or had morbid obesity that could substantially influence FA concentrations in adipose tissue. We excluded nonsubcutaneous adipose depots because of potential differences in FA composition. In cases in which data from a study were reported in more than one publication, only results from the first report were included.
When provided in the manuscript, the date of adipose tissue sampling was used for analyses. When the date of sampling was not provided, the date of publication was used. Nineteen publications provided a sampling date, whereas 18 did not. More recent publications were more likely to provide a sampling date. In cases in which the date provided was a range, the mean value was used.
US LA intake data between 1909 and 1999 were estimated from USDA Economic Research Service food disappearance data, as previously described (14). A tabular version of the data was generously provided by Joseph R Hibbeln, MD (National Institute of Alcohol Abuse and Alcoholism). These data do not extend beyond 1999, and therefore the correlation analysis between LA intake and adipose tissue LA also does not extend beyond that date.
Statistics were performed in publicly available R software. Statistical significance was determined with the use of linear regression analysis.
Results
We identified 37 studies that met inclusion criteria, reporting 38 measurements of subcutaneous adipose tissue LA (Table 1). Publication dates ranged from 1959 to 2008, with no studies identified after this period. The most common sampling site was the buttocks (n = 20), although data also represent abdominal (n = 7), breast adipose (n = 4), posterior iliac crest (n = 2), calf (n = 1), perineum (n = 1), and unspecified subcutaneous adipose tissue (n = 3).
Studies included in the analysis1
| Publication . | Date . | % LA . | Sample date . | Site . | Notes . |
|---|---|---|---|---|---|
| Hirsch et al. (16) | 1960 | 9.9 | NS | Buttocks | |
| Gellhorn et al. (17) | 1961 | 9.5 | NS | Unspecified SC | |
| Scott et al. (18) | 1962 | 9.5 | NS | Abdominal SC | |
| Hegsted et al. (19) | 1962 | 7.9 | NS | Unspecified SC | |
| Dayton et al. (20) | 1962 | 9 | 1959 | Buttocks | Baseline |
| Lee et al. (21) | 1962 | 12.1, 11.2 | NS | Buttocks | US whites and blacks |
| Lee et al. (22) | 1962 | 11.55 | NS | Buttocks | Nondiabetics |
| Sweeney et al. (23) | 1963 | 10.6 | NS | Perineum SC | Mothers |
| Remenchik et al. (24) | 1963 | 7.56 | NS | Abdominal SC | |
| Christakis et al. (25) | 1965 | 9.7 | NS | Buttocks | Baseline |
| Rabinowitz et al. (26) | 1965 | 8.7 | NS | Abdominal SC | Baseline |
| Dayton et al. (10) | 1966 | 11 | 1961 (estimated) | Buttocks | |
| Insull et al. (27) | 1967 | 9.2 | 1962 | Abdominal SC | |
| Fleischman et al. (28) | 1968 | 11 | NS | Buttocks | Baseline |
| Baker et al. (29) | 1969 | 8.2 | NS | Abdominal SC | Adults |
| Insull et al. (30) | 1969 | 10.21 | 1966 | Abdominal SC | |
| Insull et al. (31) | 1970 | 10.2 | 1962, 1966 | Abdominal SC | US whites and blacks |
| Witting et al. (32) | 1975 | 13 | 1973 | Buttocks | |
| Kokatnur et al. (33) | 1979 | 11.5 | 1969–1971 | Buttocks | |
| Fordyce et al. (34) | 1983 | 13.68 | NS | Posterior iliac crest | US-born Americans |
| Berry et al. (35) | 1986 | 16.3 | 1981–1982 | Buttocks | |
| Hill et al. (36) | 1987 | 15.8 | NS | Breast adipose | Controls |
| Handelman et al. (37) | 1988 | 18.2 | 1986 | Buttocks | |
| Malcom et al. (38) | 1989 | 15.37 | 1986–1987 | Buttocks | |
| Hudgins et al. (39) | 1991 | 16.91 | 1981 | Buttocks | |
| London et al. (40) | 1991 | 17.23 | 1986–1987 | Buttocks | |
| Hunter et al. (41) | 1992 | 19 | 1986–1987 | Buttocks | |
| London et al. (42) | 1993 | 17.72 | 1986–1988 | Buttocks | |
| Phinney et al. (43) | 1994 | 18.72 | NS | Unspecified SC | |
| Godley et al. (44) | 1996 | 17.57 | 1989–1991 | Buttocks | |
| Petrek et al. (45) | 1997 | 16.59 | 1987–1989 | Breast adipose | |
| Garland et al. (46) | 1998 | 18.5 | 1986–1987 | Buttocks | |
| Ullrich et al. (47) | 2001 | 18 | NS | Posterior iliac crest | Controls |
| Bagga et al. (48) | 2002 | 13.9 | 1995–1996 | Breast adipose | Controls |
| Knutsen et al. (49) | 2003 | 20.1 | NS | Buttocks | |
| Ren et al. (50) | 2008 | 23.4 | NS | Calf SC | |
| Yee et al. (51) | 2010 | 18 | 2006–2008 | Breast adipose | Baseline |
| Publication . | Date . | % LA . | Sample date . | Site . | Notes . |
|---|---|---|---|---|---|
| Hirsch et al. (16) | 1960 | 9.9 | NS | Buttocks | |
| Gellhorn et al. (17) | 1961 | 9.5 | NS | Unspecified SC | |
| Scott et al. (18) | 1962 | 9.5 | NS | Abdominal SC | |
| Hegsted et al. (19) | 1962 | 7.9 | NS | Unspecified SC | |
| Dayton et al. (20) | 1962 | 9 | 1959 | Buttocks | Baseline |
| Lee et al. (21) | 1962 | 12.1, 11.2 | NS | Buttocks | US whites and blacks |
| Lee et al. (22) | 1962 | 11.55 | NS | Buttocks | Nondiabetics |
| Sweeney et al. (23) | 1963 | 10.6 | NS | Perineum SC | Mothers |
| Remenchik et al. (24) | 1963 | 7.56 | NS | Abdominal SC | |
| Christakis et al. (25) | 1965 | 9.7 | NS | Buttocks | Baseline |
| Rabinowitz et al. (26) | 1965 | 8.7 | NS | Abdominal SC | Baseline |
| Dayton et al. (10) | 1966 | 11 | 1961 (estimated) | Buttocks | |
| Insull et al. (27) | 1967 | 9.2 | 1962 | Abdominal SC | |
| Fleischman et al. (28) | 1968 | 11 | NS | Buttocks | Baseline |
| Baker et al. (29) | 1969 | 8.2 | NS | Abdominal SC | Adults |
| Insull et al. (30) | 1969 | 10.21 | 1966 | Abdominal SC | |
| Insull et al. (31) | 1970 | 10.2 | 1962, 1966 | Abdominal SC | US whites and blacks |
| Witting et al. (32) | 1975 | 13 | 1973 | Buttocks | |
| Kokatnur et al. (33) | 1979 | 11.5 | 1969–1971 | Buttocks | |
| Fordyce et al. (34) | 1983 | 13.68 | NS | Posterior iliac crest | US-born Americans |
| Berry et al. (35) | 1986 | 16.3 | 1981–1982 | Buttocks | |
| Hill et al. (36) | 1987 | 15.8 | NS | Breast adipose | Controls |
| Handelman et al. (37) | 1988 | 18.2 | 1986 | Buttocks | |
| Malcom et al. (38) | 1989 | 15.37 | 1986–1987 | Buttocks | |
| Hudgins et al. (39) | 1991 | 16.91 | 1981 | Buttocks | |
| London et al. (40) | 1991 | 17.23 | 1986–1987 | Buttocks | |
| Hunter et al. (41) | 1992 | 19 | 1986–1987 | Buttocks | |
| London et al. (42) | 1993 | 17.72 | 1986–1988 | Buttocks | |
| Phinney et al. (43) | 1994 | 18.72 | NS | Unspecified SC | |
| Godley et al. (44) | 1996 | 17.57 | 1989–1991 | Buttocks | |
| Petrek et al. (45) | 1997 | 16.59 | 1987–1989 | Breast adipose | |
| Garland et al. (46) | 1998 | 18.5 | 1986–1987 | Buttocks | |
| Ullrich et al. (47) | 2001 | 18 | NS | Posterior iliac crest | Controls |
| Bagga et al. (48) | 2002 | 13.9 | 1995–1996 | Breast adipose | Controls |
| Knutsen et al. (49) | 2003 | 20.1 | NS | Buttocks | |
| Ren et al. (50) | 2008 | 23.4 | NS | Calf SC | |
| Yee et al. (51) | 2010 | 18 | 2006–2008 | Breast adipose | Baseline |
LA, linoleic acid; NS, not specified; SC, subcutaneous adipose tissue.
Studies included in the analysis1
| Publication . | Date . | % LA . | Sample date . | Site . | Notes . |
|---|---|---|---|---|---|
| Hirsch et al. (16) | 1960 | 9.9 | NS | Buttocks | |
| Gellhorn et al. (17) | 1961 | 9.5 | NS | Unspecified SC | |
| Scott et al. (18) | 1962 | 9.5 | NS | Abdominal SC | |
| Hegsted et al. (19) | 1962 | 7.9 | NS | Unspecified SC | |
| Dayton et al. (20) | 1962 | 9 | 1959 | Buttocks | Baseline |
| Lee et al. (21) | 1962 | 12.1, 11.2 | NS | Buttocks | US whites and blacks |
| Lee et al. (22) | 1962 | 11.55 | NS | Buttocks | Nondiabetics |
| Sweeney et al. (23) | 1963 | 10.6 | NS | Perineum SC | Mothers |
| Remenchik et al. (24) | 1963 | 7.56 | NS | Abdominal SC | |
| Christakis et al. (25) | 1965 | 9.7 | NS | Buttocks | Baseline |
| Rabinowitz et al. (26) | 1965 | 8.7 | NS | Abdominal SC | Baseline |
| Dayton et al. (10) | 1966 | 11 | 1961 (estimated) | Buttocks | |
| Insull et al. (27) | 1967 | 9.2 | 1962 | Abdominal SC | |
| Fleischman et al. (28) | 1968 | 11 | NS | Buttocks | Baseline |
| Baker et al. (29) | 1969 | 8.2 | NS | Abdominal SC | Adults |
| Insull et al. (30) | 1969 | 10.21 | 1966 | Abdominal SC | |
| Insull et al. (31) | 1970 | 10.2 | 1962, 1966 | Abdominal SC | US whites and blacks |
| Witting et al. (32) | 1975 | 13 | 1973 | Buttocks | |
| Kokatnur et al. (33) | 1979 | 11.5 | 1969–1971 | Buttocks | |
| Fordyce et al. (34) | 1983 | 13.68 | NS | Posterior iliac crest | US-born Americans |
| Berry et al. (35) | 1986 | 16.3 | 1981–1982 | Buttocks | |
| Hill et al. (36) | 1987 | 15.8 | NS | Breast adipose | Controls |
| Handelman et al. (37) | 1988 | 18.2 | 1986 | Buttocks | |
| Malcom et al. (38) | 1989 | 15.37 | 1986–1987 | Buttocks | |
| Hudgins et al. (39) | 1991 | 16.91 | 1981 | Buttocks | |
| London et al. (40) | 1991 | 17.23 | 1986–1987 | Buttocks | |
| Hunter et al. (41) | 1992 | 19 | 1986–1987 | Buttocks | |
| London et al. (42) | 1993 | 17.72 | 1986–1988 | Buttocks | |
| Phinney et al. (43) | 1994 | 18.72 | NS | Unspecified SC | |
| Godley et al. (44) | 1996 | 17.57 | 1989–1991 | Buttocks | |
| Petrek et al. (45) | 1997 | 16.59 | 1987–1989 | Breast adipose | |
| Garland et al. (46) | 1998 | 18.5 | 1986–1987 | Buttocks | |
| Ullrich et al. (47) | 2001 | 18 | NS | Posterior iliac crest | Controls |
| Bagga et al. (48) | 2002 | 13.9 | 1995–1996 | Breast adipose | Controls |
| Knutsen et al. (49) | 2003 | 20.1 | NS | Buttocks | |
| Ren et al. (50) | 2008 | 23.4 | NS | Calf SC | |
| Yee et al. (51) | 2010 | 18 | 2006–2008 | Breast adipose | Baseline |
| Publication . | Date . | % LA . | Sample date . | Site . | Notes . |
|---|---|---|---|---|---|
| Hirsch et al. (16) | 1960 | 9.9 | NS | Buttocks | |
| Gellhorn et al. (17) | 1961 | 9.5 | NS | Unspecified SC | |
| Scott et al. (18) | 1962 | 9.5 | NS | Abdominal SC | |
| Hegsted et al. (19) | 1962 | 7.9 | NS | Unspecified SC | |
| Dayton et al. (20) | 1962 | 9 | 1959 | Buttocks | Baseline |
| Lee et al. (21) | 1962 | 12.1, 11.2 | NS | Buttocks | US whites and blacks |
| Lee et al. (22) | 1962 | 11.55 | NS | Buttocks | Nondiabetics |
| Sweeney et al. (23) | 1963 | 10.6 | NS | Perineum SC | Mothers |
| Remenchik et al. (24) | 1963 | 7.56 | NS | Abdominal SC | |
| Christakis et al. (25) | 1965 | 9.7 | NS | Buttocks | Baseline |
| Rabinowitz et al. (26) | 1965 | 8.7 | NS | Abdominal SC | Baseline |
| Dayton et al. (10) | 1966 | 11 | 1961 (estimated) | Buttocks | |
| Insull et al. (27) | 1967 | 9.2 | 1962 | Abdominal SC | |
| Fleischman et al. (28) | 1968 | 11 | NS | Buttocks | Baseline |
| Baker et al. (29) | 1969 | 8.2 | NS | Abdominal SC | Adults |
| Insull et al. (30) | 1969 | 10.21 | 1966 | Abdominal SC | |
| Insull et al. (31) | 1970 | 10.2 | 1962, 1966 | Abdominal SC | US whites and blacks |
| Witting et al. (32) | 1975 | 13 | 1973 | Buttocks | |
| Kokatnur et al. (33) | 1979 | 11.5 | 1969–1971 | Buttocks | |
| Fordyce et al. (34) | 1983 | 13.68 | NS | Posterior iliac crest | US-born Americans |
| Berry et al. (35) | 1986 | 16.3 | 1981–1982 | Buttocks | |
| Hill et al. (36) | 1987 | 15.8 | NS | Breast adipose | Controls |
| Handelman et al. (37) | 1988 | 18.2 | 1986 | Buttocks | |
| Malcom et al. (38) | 1989 | 15.37 | 1986–1987 | Buttocks | |
| Hudgins et al. (39) | 1991 | 16.91 | 1981 | Buttocks | |
| London et al. (40) | 1991 | 17.23 | 1986–1987 | Buttocks | |
| Hunter et al. (41) | 1992 | 19 | 1986–1987 | Buttocks | |
| London et al. (42) | 1993 | 17.72 | 1986–1988 | Buttocks | |
| Phinney et al. (43) | 1994 | 18.72 | NS | Unspecified SC | |
| Godley et al. (44) | 1996 | 17.57 | 1989–1991 | Buttocks | |
| Petrek et al. (45) | 1997 | 16.59 | 1987–1989 | Breast adipose | |
| Garland et al. (46) | 1998 | 18.5 | 1986–1987 | Buttocks | |
| Ullrich et al. (47) | 2001 | 18 | NS | Posterior iliac crest | Controls |
| Bagga et al. (48) | 2002 | 13.9 | 1995–1996 | Breast adipose | Controls |
| Knutsen et al. (49) | 2003 | 20.1 | NS | Buttocks | |
| Ren et al. (50) | 2008 | 23.4 | NS | Calf SC | |
| Yee et al. (51) | 2010 | 18 | 2006–2008 | Breast adipose | Baseline |
LA, linoleic acid; NS, not specified; SC, subcutaneous adipose tissue.
When considering all subcutaneous adipose sites, LA concentration increased in a linear manner over time (R2 = 0.83; P < 0.001) (Figure 1A). The best-fit line for adipose tissue LA increased from 9.1% in 1959 to 21.5% in 2008, representing a 136% increase.
US adipose tissue LA concentration, 1959–2008. Increase in adipose tissue LA concentration over time across all subcutaneous sites (R2 = 0.83; P < 0.001) (A). Increase in adipose tissue LA concentration over time, buttocks and abdominal subcutaneous only (R2 = 0.86; P < 0.001) (B). LA, linoleic acid.
US adipose tissue LA concentration, 1959–2008. Increase in adipose tissue LA concentration over time across all subcutaneous sites (R2 = 0.83; P < 0.001) (A). Increase in adipose tissue LA concentration over time, buttocks and abdominal subcutaneous only (R2 = 0.86; P < 0.001) (B). LA, linoleic acid.
To eliminate possible confounding because of differences in adipose tissue composition across subcutaneous sites, we repeated the analysis including only data from the buttocks and abdominal tissue, which have a comparable FA composition (38). This had little impact on the strength of the relation between time and adipose tissue LA (R2 = 0.86; P < 0.001) (Figure 1B).
Dietary LA has been shown to influence adipose tissue LA concentration in diet modification trials; however, to our knowledge, this hypothesis has never been evaluated by interrogating the correlation between LA intake and adipose tissue LA in a free-living population over a long period of time. Considering all subcutaneous sites, dietary intake of LA was highly correlated with adipose tissue LA (R2 = 0.81; P < 0.001) (Figure 2). For every kg increase of yearly per capita LA intake, adipose tissue concentration of LA increased by 2%.
Correlation between adipose tissue LA concentration (all sites) and dietary LA intake, 1959–1999. Adipose tissue LA concentration is strongly correlated with dietary LA intake (R2 = 0.81; P < 0.001). LA, linoleic acid.
Correlation between adipose tissue LA concentration (all sites) and dietary LA intake, 1959–1999. Adipose tissue LA concentration is strongly correlated with dietary LA intake (R2 = 0.81; P < 0.001). LA, linoleic acid.
Conclusions
These findings support the hypothesis that adipose tissue LA concentration has greatly increased in the United States over the last half century. Between 1959 and 2008, adipose tissue LA increased by 136%, representing a major shift in the adipose tissue concentration of a bioactive FA.
Because of its influence on multiple physiologic and pathophysiologic processes, LA has the potential to play an important role in human health. At the same time that the LA content of adipose tissue has been increasing, the United States has experienced substantial changes in disease prevalence. Cardiovascular disease risk has declined (52), whereas the prevalence of obesity (53), diabetes (54), and asthma (55) have increased. Our aim was not to evaluate the potential causal role of LA in these pathophysiologic processes, but simply to highlight that a role for LA in these trends is mechanistically possible and worthy of further investigation.
Our findings suggest that adipose tissue LA concentration is strongly correlated with dietary LA intake. This provides additional independent support for the hypothesis that long-term adipose tissue LA concentration is tied to dietary LA intake, and for the first time demonstrates that this relation applies to long-term population trends. Our analysis may also provide a basis for modeling the relation between population LA intake and adipose tissue LA. For each kg increase of estimated yearly per capita LA intake, adipose tissue LA increased by 2%. Because the half-life of LA incorporation into adipose tissue is ∼680 d (10), changes in LA intake would take several years to result in a stable increase of adipose tissue LA.
Limitations of this study relate primarily to the nature of the underlying data. The data were not the result of longitudinal random sampling of the US population, but rather were primarily small samples representing varied regions of the United States. The underlying assumption is that local data, to some extent, represent broader population trends. However, local differences in dietary habits could reduce the applicability of individual data points to the United States as a whole. Furthermore, the results shown here are from laboratories that used different methods (e.g., packed compared with liquid-phase capillary columns or total adipose FAs compared with adipose tissue TG FAs) and reporting (e.g., weight percentage or area percentage). Some of the earlier studies may not have accounted for the longer chain (20- and 22-carbon) PUFAs, effectively increasing the proportion of LA in studies reported in the earlier years. Despite differences in methods that exist in the studies included in this cross-sectional study, we are unaware of any that would produce a large and systematic increase of LA. Our results are also limited by the fact that there are gaps in years of reported studies. In addition, 18 of 37 studies did not provide a sampling date, and therefore we used the publication date in analyses. In these cases, the sampling date occurred before the publication date, but the time difference is unknown. These limitations would all be expected to increase the variability of the data and decrease the likelihood of identifying statistically significant correlations. The fact that we were nevertheless able to identify strong positive relations between adipose tissue LA concentration and time (R2 = 0.81–0.90; P < 0.001) argues that the data were of sufficient quality to address the hypotheses in question. Finally, estimates of LA intake used in Figure 2 are based on food disappearance data (14), which are not a direct measure of food intake. However, food disappearance estimates are likely more accurate than self-reported estimates, such as those from the CDC NHANES surveys, which are the primary alternative (56).
Our findings suggest that adipose tissue LA has increased substantially in the United States over the last half century, and, to our knowledge, for the first time demonstrate that this increase is highly correlated with increased dietary LA intake over the same period. Interestingly, 3 recent investigations (2013–2015) of adipose tissue LA in European countries found concentrations of 11% (57), 12.5% (58), and 10.6% (59). These values are similar to earlier reports from the United States. Because LA is in involved in numerous physiologic and pathophysiologic processes, these changes have potentially significant implications for public health. These findings call for further research into the consequences, positive or negative, of such a major shift in the adipose tissue concentration of a single bioactive FA occurring over a relatively short period of time in the United States.
Acknowledgments
We thank Joseph R Hibbeln for generously providing us with tabular data on US dietary LA intake, and Elizabeth Sosik for statistical consultation. Both authors read and approved the final manuscript.
References
Author notes
The authors report no funding for this study.
Author disclosures: SJ Guyenet and SE Carlson, no conflicts of interest.


